Diego del Alcázar

Diego del Alcázar has a strong background in the pharmaceutical and biotech industries, with expertise in pipeline and portfolio strategy, business development, and market research. Diego is currently serving as the Head of Pipeline and Portfolio Strategy - Senior Director at Forma Therapeutics since April 2021. Prior to that, they worked at Genentech as the Pipeline and Portfolio Strategy & US Commercial Operations - Franchise Lead from December 2015 to April 2021. Diego also worked at AGC Consulting as an Advisor and Research Assistant, where they provided insights and modeling support for biopharma companies from June 2014 to December 2015. Additionally, they gained experience in business development as an M.B.A. Intern at Sanofi-Genzyme in 2013. Diego started their career in 2004 as a Market Research Analyst at sanofi-aventis and later transitioned to roles in corporate strategy and financial advisory services at Deloitte and management consulting at Accenture. Throughout their career, Diego has demonstrated their ability to drive strategic decision-making, deliver valuable insights, and generate business growth.

Diego del Alcázar pursued various educational opportunities throughout their career. Diego obtained a Master of Business Administration (M.B.A.) degree from Northwestern University's Kellogg School of Management between 2012 and 2014, specializing in Health Enterprise Management, Marketing, Strategy, and Decision Sciences. In 2007, they completed an Executive Education program at IE Business School, focusing on Banking, Corporate, Finance, and Securities Law. Diego also holds a Bachelor's degree in Business Administration (E-2) from Universidad Pontificia Comillas, which they earned between 1999 and 2004. Additionally, they attended Yale University in 2000 to study Business Administration and Management.